1998
DOI: 10.1002/1529-0131(199805)41:5<935::aid-art22>3.0.co;2-n
|View full text |Cite
|
Sign up to set email alerts
|

Segmental mediolytic arteriopathy of the splenic and hepatic arteries mimicking systemic necrotizing vasculitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
28
0

Year Published

2002
2002
2015
2015

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(29 citation statements)
references
References 7 publications
1
28
0
Order By: Relevance
“…A subsequent review of the resected vessel led to the correct diagnosis of segmental mediolytic arteriopathy, a variant of fibromuscular dysplasia. [30]. All these cases had an acute presentation with radiologic and laboratory features suggesting a vasculitic process.…”
Section: Fibromuscular Dysplasiamentioning
confidence: 96%
“…A subsequent review of the resected vessel led to the correct diagnosis of segmental mediolytic arteriopathy, a variant of fibromuscular dysplasia. [30]. All these cases had an acute presentation with radiologic and laboratory features suggesting a vasculitic process.…”
Section: Fibromuscular Dysplasiamentioning
confidence: 96%
“…Surgical or interventional repair of aneurysms and endovascular stenting of arterial dissections may be necessary. Because of the similarity of SMA to polyarteritis nodosa, surgery with histopathological analysis for better differentiation has been proposed [15]. Considering the normally perfused mesenteric vessels, hypoperfusion due to low cardiac output is the most probable cause of the bowel ischemia in this case Fig.…”
Section: Segmental Mediolytic Arteriopathymentioning
confidence: 97%
“…47,50,53 The differential diagnosis of SAM includes vasculitides (mainly PAN, Behç et disease, and TAK), mycotic aneurysm, and noninflammatory vasculopathies such as FMD, Ehlers-Danlos syndrome type IV, cystic adventitial artery disease, and cystic medial necrosis (eg, Marfan syndrome). 54,55 No serum or genetic biomarker is available for the diagnosis of SAM.…”
Section: Segmental Arterial Mediolysismentioning
confidence: 99%